• Home
  • /
  • Generative AI for Protein Design, Antibodies, and Therapeutic Discovery

May 2, 2026

Registration closes May 2, 2026

Generative AI for Protein Design, Antibodies, and Therapeutic Discovery

Design the Next Generation of Therapeutics with Generative AI

  • Mode: Virtual / Online
  • Type: Mentor Based
  • Level:
  • Duration: 3 Days (1.5 Hours Per Day)
  • Starts: 2 May 2026
  • Time: 8:00 PM IST

About This Course

This workshop introduces the key concepts behind protein language models, diffusion models, structure-based generative design, antibody optimization, and AI-assisted biologics development. Participants will explore applications in antibody discovery, antigen binding prediction, protein stability improvement, enzyme engineering, and therapeutic candidate screening.

Aim

This workshop aims to introduce participants to the use of Generative AI in protein engineering, antibody design, and therapeutic discovery. It focuses on how AI models can generate, optimize, and evaluate novel protein and antibody candidates. Participants will learn how generative models support sequence design, structure prediction, affinity improvement, and developability assessment. The program bridges computational biology, AI, and next-generation biologics discovery.

Workshop Objectives

  • Understand how generative AI is used in protein and antibody design.
  • Learn sequence-based and structure-based protein generation concepts.
  • Explore antibody design, binding affinity prediction, and developability analysis.
  • Understand protein stability, specificity, and functional optimization strategies.
  • Connect AI-generated candidates to therapeutic discovery workflows.

Workshop Structure


Day 1: Foundations of Protein AI and Structure Prediction 

  • Protein databases and sequence annotation
  • Structure confidence, pLDDT, and basic model interpretation
  • Search a protein sequence using UniProt
  • Explore known structures using RCSB PDB
  • View predicted structures using AlphaFold DB
  • Predict or explore a protein structure using ColabFold / ESMFold demo
  • Visualize protein structure using Mol* / PyMOL
  • Tools: Google Colab, NCBI, PubMed / literature search & demo & UniProt

Day 2: Generative AI for Protein Design and Engineering 

  • Generate or explore protein sequence embeddings using a demo notebook
  • Understand RFdiffusion-based protein scaffold/binder design workflow
  • Use ProteinMPNN concept workflow for sequence redesign
  • Compare native vs designed protein sequences
  • Visualize designed protein structures
  • Discuss developability checks: stability, solubility, immunogenicity, and manufacturability
  • Tools: Google Colab, NCBI, PubMed / literature search & demo & UniProt

Day 3: Generative AI for Antibodies and Therapeutic Discovery 

  • Explore antibody sequence and structure basics
  • Predict or view antibody structure using IgFold demo
  • Identify CDR regions and binding-relevant regions
  • Visualize antibody–antigen interaction concept
  • Perform a basic docking workflow demonstration
  • Create a therapeutic discovery workflow map
  • Prepare a simple AI model validation checklist
  • Tools: Google Colab, NCBI, PubMed / literature search & demo & UniProt

Important Dates

Registration Ends

May 2, 2026
IST 7:00 PM

Workshop Dates

May 2, 2026 – May 4, 2026
IST 8:00 PM

Workshop Outcomes

Participants will be able to:

  • Explain how generative AI accelerates protein and antibody discovery.
  • Understand AI workflows for designing and optimizing therapeutic proteins.
  • Interpret outputs from protein language and structure-based AI models.
  • Identify key developability factors for biologics candidates.
  • Apply AI-driven thinking to therapeutic discovery and biologics R&D.

Meet Your Mentor(s)

Mentor Photo

DR. HARISHCHANDER ANANDARAM

Assistant Professor

Dr Harishchander Anandaram is an Assistant Professor at Centre for Excellence in Computational Engineering and Networking, Amrita Vishwa Vidyapeetham, Coimbatore, Tamil Nadu, India. He received his Ph.D. Degree in Bioengineering from Sathyabama Institute of Science and Technology, Chennai, in 2020. . . . In his PhD thesis, he worked on pharmacogenomics and miRNA- regulated networks in psoriasis, a joint project with Georgetown University, USA, JIPMER, INDIA, CIBA, INDIA, and ILS, INDIA. His thesis illustrated a multi-disciplinary approach by combining computational biophysics and molecular biology machine learning. Also, he had the opportunity to collaborate with international researchers and have publications in reputed international journals in bioinformatics and systems biology simultaneously. He has received the prestigious “Young Scientist Award” from “The Melinda Gates Foundation” for his research abstract on “The Implications of miRNA Dynamics in Infectious Diseases”. To date, he has reviewed more than 200 manuscripts in systems biology. He is currently working on predicting Novel lead molecules and biomarkers using computational techniques to target inflammatory pathways associated with infectious and autoimmune disorders.

Fee Structure

Student Fee

₹2499 | $65

Ph.D. Scholar / Researcher Fee

₹3499 | $75

Academician / Faculty Fee

₹4499 | $87

Industry Professional Fee

₹5499 | $95

What You’ll Gain

  • Live & recorded sessions
  • e-Certificate upon completion
  • Post-workshop query support
  • Hands-on learning experience

Need Help?

We’re here for you!


(+91) 120-4781-217

★★★★★
Cancer Drug Discovery: Creating Cancer Therapies

Undoubtedly, the professor's expertise was evident, and their ability to cover a vast amount of material within the given timeframe was impressive. However, the pace at which the content was presented made it challenging for some attendees, including myself, to fully grasp and absorb the information.

Mario Rigo
★★★★★
Power BI and Advanced SQL Mastery Integration Workshop, CRISPR-Cas Genome Editing: Workflow, Tools and Techniques

Good! Thank you

Silvia Santopolo
★★★★★
Artificial Intelligence for Cancer Drug Delivery

Informative lectures

G Jyothi
★★★★★
Artificial Intelligence for Cancer Drug Delivery

delt with all the topics associated with the subject matter

RAVIKANT SHEKHAR

View All Feedbacks →